Search

Your search keyword '"Zhou, Huafeng"' showing total 250 results

Search Constraints

Start Over You searched for: Author "Zhou, Huafeng" Remove constraint Author: "Zhou, Huafeng"
250 results on '"Zhou, Huafeng"'

Search Results

3. Experimental Study on the Shear Strength Parallel to the Fibers of Original Bamboo

7. Active Learning Based Labeling Method for Fault Disposal Pre-plans

8. MECaaS: Mobile Edge Computing as a Services Based on Blockchain

24. Facial synthesis of MCeOx/porous carbon (M = Fe, Ni, and Co) composites with dielectric/magnetic properties for microwave absorption.

25. TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy.

28. Ultra‐light fluorinated polyimide foams with excellent thermal insulation, low dielectric loss and high heat resistance.

29. Urea-Assisted Green Synthesis of CeO2 Nanoparticles/Porous Carbon Composites for Microwave Absorption.

30. A triboelectric nanogenerator based on TPU/PVDF electrospinning for mechanical energy harvesting and monitoring running step rate.

31. Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3

37. Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

40. Evaluation of setting and hardening properties of accelerator and slag-silica fume-cements

41. Meshing impact analysis of the gear and rack of the pumping machine based on the SPH–FEM coupling method.

42. Updated outcomes in TROPHY-U-01 cohort 1, a phase 2 study of sacituzumab govitecan (SG) in patients (pts) with metastatic urothelial cancer (mUC) that progressed after platinum (PT)-based chemotherapy and a checkpoint inhibitor (CPI).

43. Primary analysis of TROPHY-U-01 cohort 3, a phase 2 study of sacituzumab govitecan (SG) in combination with pembrolizumab (Pembro) in patients (pts) with metastatic urothelial cancer (mUC) that progressed after platinum (PT)-based therapy.

44. Primary analysis of TROPHY-U-01 cohort 2, a phase 2 study of sacituzumab govitecan (SG) in platinum (PT)-ineligible patients (pts) with metastatic urothelial cancer (mUC) that progressed after prior checkpoint inhibitor (CPI) therapy.

49. Healthy Behavior Change of Adults with Mental Retardation: Attendance in a Health Promotion Program

50. Construction of lychee-like MoS2 microspheres on rice husk-derived porous carbon for enhanced dielectric loss and efficient electromagnetic wave absorption.

Catalog

Books, media, physical & digital resources